Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    0(0%)
    Results Posted
    100%(1 trials)

    Phase Distribution

    Not Applicable
    1
    50%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    N/ANon-phased studies
    1(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(1)
    Other(1)

    Detailed Status

    unknown1
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A1 (100.0%)

    Trials by Status

    unknown150%
    completed150%

    Recent Activity

    0 active trials
    Showing 2 of 2
    unknownnot_applicable

    Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease

    NCT05814068
    completed

    Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

    NCT01173029

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT05814068Not Applicable

    Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease

    Unknown
    NCT01173029

    Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2